Back
Speaker illustration

Miss Yiran Zhou

Stockholm (Sweden)

Presentations

Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status

Event: ESC Congress 2025

Topic: Device Treatment

Session: Ventricular arrhythmias

Access
Like
Thumbnail

Indications, prognosis, and complications of de novo implantable cardioverter defibrillators in patients with type 2 diabetes and without diabetes

Event: ESC Congress 2025

Topic: Device Treatment

Session: Ventricular arrhythmias

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources